Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Dec 10, 2014 5:13pm

197 Views

Post# 23216988

RE:RE:RE:RE:Is Theralase one of the Lucky Ones?

bencro, your quote, " By the way, how come you don't know when the reps are trained on TLC-2000"? Well I'm quite sure that even you didn't know what you were referring to here. Did HC give approval yet? Please clarify! Now back to the original issue, who told you that surgery tumor reduction was going to be involved in any of the TLT studies?? By the way, when can we expect an update on U of Mass ph1 human trial status? You may remember that was your posting circus.

Bullboard Posts

Arbor Metals completes Phase 1 drilling at Jarnet lithium project